Canada Markets close in 4 hrs 9 mins

Fennec Pharmaceuticals Inc. (FRX.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
5.76+0.26 (+4.73%)
As of 03:23PM EST. Market open.
Currency in CAD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.09
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 313.25
52 Week Low 34.95
50-Day Moving Average 311.01
200-Day Moving Average 39.36

Share Statistics

Avg Vol (3 month) 31.5k
Avg Vol (10 day) 35.16k
Shares Outstanding 526M
Implied Shares Outstanding 6N/A
Float 819.84M
% Held by Insiders 116.94%
% Held by Institutions 156.33%
Shares Short (Jun. 14, 2021) 4148.06k
Short Ratio (Jun. 14, 2021) 4236.53
Short % of Float (Jun. 14, 2021) 40.84%
Short % of Shares Outstanding (Jun. 14, 2021) 40.57%
Shares Short (prior month May 13, 2021) 441.94k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:3
Last Split Date 3Sep. 04, 2014

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Mar. 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-11,160.59%

Management Effectiveness

Return on Assets (ttm)-62.10%
Return on Equity (ttm)-113.89%

Income Statement

Revenue (ttm)170k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)170k
Net Income Avi to Common (ttm)-19.02M
Diluted EPS (ttm)-0.93
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)26.75M
Total Cash Per Share (mrq)1.03
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)9.62
Book Value Per Share (mrq)0.96

Cash Flow Statement

Operating Cash Flow (ttm)-15.44M
Levered Free Cash Flow (ttm)-8.52M